Human T cell leukemia virus type I and neurologic disease: Events in bone marrow, peripheral blood, and central nervous system during normal immune surveillance and neuroinflammation

Journal of Cellular Physiology

Volumn 190, Issue 2, 2002, Pages 133-159

  Grant, Christian ^a   Barmak, Kate ^a   Alefantis, Timothy ^a   Yao, Jing ^a   Jacobson, Steven ^b   Wigdahl, Brian ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MYELIN; VIRUS ANTIBODY; VIRUS DNA;

ASTROCYTE; B LYMPHOCYTE; CELL DIFFERENTIATION; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; ENVIRONMENTAL FACTOR; GENE ACTIVATION; GENE EXPRESSION; HEMATOPOIETIC STEM CELL; HUMAN T CELL LEUKEMIA VIRUS 1; IMMUNE RESPONSE; IMMUNOSURVEILLANCE; INFLAMMATION; MONOCYTE; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SPASTIC PARAPLEGIA; SPINAL CORD DISEASE; T CELL LEUKEMIA; T LYMPHOCYTE; VIRUS GENOME; VIRUS INFECTION; VIRUS LOAD;

ANIMALS; BONE MARROW; CENTRAL NERVOUS SYSTEM; HTLV-I INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; IMMUNOLOGIC SURVEILLANCE; NERVOUS SYSTEM DISEASES; NEURITIS; VIREMIA;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN T-LYMPHOTROPIC VIRUS 1;

EID: 0036135070     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.10053     Document Type: Review

References (207)

1. Activation of macrophages/microglia with the calcium-binding proteins MRP14 and MRP8 is related to the lesional activities in the spinal cord of HTLV-I associated myelopathy
2. Expansion of CREB's DNA recognition specificity by Tax results from interaction with Ala-Ala-Arg at positions 282-284 near the conserved DNA-binding domain of CREB
3. + progenitors to peripheral blood
4. Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen
5. Quantification of human T-cell lymphotropic virus type 1 proviral load by quantitative competitive polymerase chain reaction
6. Human T-lymphotropic virus type 1 open reading frame I p12(I) is required for efficient viral infectivity in primary lymphocytes
7. Regulation of T-cell responses by CNS antigen-presenting cells: Different roles for microglia and astrocytes
8. Chemokines and leukocyte traffic
9. HTLV-I tax induces cellular proteins that activate the kappa B element in the IL-2 receptor alpha gene
10. Dendritic cells and the control of immunity
11. The immune response to HTLV-I
12. Mechanism of DNA-binding enhancement by the human T-cell leukaemia virus transactivator Tax
13. Function of the human T-cell leukemia virus type 1 21-base pair repeats in basal transcription
14. Functional role of pX open reading frame II of human T-lymphotropic virus type 1 in maintenance of viral loads in vivo
15. Human T-cell-leukemia virus type I in posttransfusional spastic paraparesis: Complete proviral sequence from uncultured blood cells
16. Lymphocyte migration in lymphocyte function-associated antigen (LFA)-1-deficient mice
17. Identification of MIP-1 alpha/LD78 as a monocyte chemoattractant released by the HTLV-I-transformed cell line MT4
18. Detection of human T-cell lymphoma/leukemia virus type I DNA and antigen in spinal fluid and blood of patients with chronic progressive myelopathy
19. Reciprocal expression of human ETS1 and ETS2 genes during T-cell activation: Regulatory role for the protooncogene ETS1
20. Cooperation of Sp1 and p300 in the induction of the CDK inhibitor p21WAF1/CIP1 during NGF-mediated neuronal differentiation
21. Sp1 and kruppel-like factor family of transcription factors in cell growth regulation and cancer
22. The product of the c-ets-1 proto-oncogene and the related Ets2 protein act as transcriptional activators of the long terminal repeat of human T cell leukemia virus HTLV-1
23. Myb protein binds to multiple sites in the human T cell lymphotropic virus type 1 long terminal repeat and transactivates LTR-mediated expression
24. Identification of p40-xresponsive regulatory sequences within the human T-cell leukemia virus type I long terminal repeat
25. A molecular mechanism for human T-cell leukemia virus latency and Tax transactivation
26. HTLV-I-induced T-cell activation
27. Human T-cell leukemia virus type 1 Tax shuttles between functionally discrete subcellular targets
28. Long terminal repeats of human T-cell leukaemia virus II genome determine target cell specificity
29. In vivo proviral burden and viral RNA expression in T cell subsets of patients with human T lymphotropic virus type-1-associated myelopathy/tropical spastic paraparesis
30. Preferred nucleotide sequence at the integration target site of human T-cell leukemia virus type I from patients with adult T-cell leukemia
31. Mitochondrial targeting of the p13II protein coded by the x-II ORF of human T-cell leukemia/lymphotropic virus type I (HTLV-I)
32. Activation of the human T-cell leukemia virus type I enhancer is mediated by binding sites for Elf-1 and the pets factor
33. The human T-cell leukemia virus type 1 oncoprotein Tax inhibits the transcriptional activity of c-Myb through competition for the CREB binding protein
34. Requirement of MIP-1 alpha for an inflammatory response to viral infection
35. Expression directed from HIV long terminal repeats in the central nervous system of transgenic mice
36. Sequence variants of human T-cell lymphotropic virus type I from patients with tropical spastic paraparesis and adult T-cell leukemia do not distinguish neurological from leukemic isolates
37. In vivo genomic footprinting of the human T-cell leukemia virus type 1 (HTLV-1) long terminal repeat enhancer sequences in HTLV-1-infected human T-cell lines with different levels of Tax I activity
38. PU. 1 regulates both cytok-inedependent proliferation and differentiation of granulocyte/macrophage progenitors
39. X-I and X-II open reading frames of HTLV-I are not required for virus replication or for immortalization of primary T-cells in vitro
40. Increased expression of alpha 4 beta 1 and alpha 5 beta 1 integrins on HTLV-I-infected lymphocytes
41. Extracellular human T-cell lymphotropic virus type I Tax protein induces cytokine production in adult human microglial cells
42. Four A6-TCR/peptide/HLA-A2 structures that generate very different T cell signals are nearly identical
43. Endoplasmic reticulum and cis-Golgi localization of human T-lymphotropic virus type 1 p12(I): Association with calreticulin and calnexin
44. Loss of CCR2 expression and functional response to monocyte chemotactic protein (MCP-1) during the differentiation of human monocytes: Role of secreted MCP-1 in the regulation of the chemotactic response
45. Human T-cell leukemia virus infection of human hematopoietic progenitor cells: Maintenance of virus infection during differentiation in vitro and in vivo
46. Role of PU.1 in hematopoiesis
47. Tumor necrosis factor alpha expression in the spinal cord of human T-cell lymphotrophic virus type I associated myelopathy/tropical spastic paraparesis patients
48. + ATPase
49. Transactivation by the human T-cell leukemia virus Tax protein is mediated through enhanced binding of activating transcription factor-2 (ATF-2) ATF-2 response and cAMP elementbinding protein (CREB)
50. C-fos promoter transactivation by the tax1 protein of human T-cell leukemia virus type I
51. HTLV-1 Tax induces expression of various immediate early serum responsive genes
52. Interaction of HTLV-1 Tax1 with p67SRF causes the aberrant induction of cellular immediate early genes through CArG boxes
53. C-Jun, c-Fos and their family members activate the transcription mediated by three 21-bp repetitive sequences in the HTLV-I long terminal repeat
54. Heightened transmigrating activity of CD4-positive T cells through reconstituted basement membrane in patients with human T-lymphotropic virus type I-associated myelopathy
55. Elevated levels of interleukin-12 and interferon-gamma in patients with human T lymphotropic virus type I-associated myelopathy
56. Assembly, specific binding, and crystallization of a human TCR-alphabeta with an antigenic Tax peptide from human T lymphotropic virus type 1 and the class I MHC molecule HLA-A2
57. Highly divergent molecular variants of human T-lymphotropic virus type I from isolated populations in Papua New Guinea and the Solomon Islands
58. Anchoring of CREB binding protein to the human T-cell leukemia virus type 1 promoter: A molecular mechanism of Tax transactivation
59. Transcriptional activation of the human T-lymphotropic virus type I long terminal repeat by functional interaction of Tax1 and Ets1
60. Tissue expression pattern directed in transgenic mice by the LTR of an HTLV-I provirus isolated from a case of tropical spastic paraparesis
61. Gene regulation mediated by interaction between HTLV-1 promoter elements and transcription factors Tax and CREB
62. Dendritic cells: Multi-lineal and multi-functional
63. Direct visualization of antigen-specific T cells: HTLV-1 Tax11-x19-specific CD8(+) T cells are activated in peripheral blood and accumulate in cerebrospinal fluid from HAM/TSP patients
64. High frequency of viral protein expression in human T cell lymphotropic virus type 1-infected peripheral blood mononuclear cells
65. Detection of human T lymphotrophic virus type I (HTLV-I) proviral DNA and analysis of T cell receptor V beta CDR3 sequences in spinal cord lesions of HTLV-I-associated myelopathy/tropical spastic paraparesis
66. Gene expression profiles in HTLV-I-immortalized T cells: Deregulated expression of genes involved in apoptosis regulation
67. T-lymphocyte entry into the central nervous system
68. Tax protein of human T-cell leukemia virus type I binds to the ankyrin motifs of inhibitory factor kappa B and induces nuclear translocation of transcription factor NF-kappa B proteins for transcriptional activation
69. Human T-cell leukemia virus type I infection of monocytes and microglial cells in primary human cultures
70. Mechanisms of T-cell activation by human T-cell lymphotropic virus type I
71. Pathogenesis of diseases induced by human lymphotropic virus type I infection
72. The human T-cell leukemia virus type I (HTLV-I) X region encoded protein p13(II) interacts with cellular proteins
73. Human T-cell leukemia virus type 1 tax protein activates transcription through AP-1 site by inducing DNA binding activity in T cells
74. Cellular immune responses to HTLV-I: Immunopathogenic role in HTLV-I-associated neurologic disease
75. Isolation of an HTLV-1-like retrovirus from patients with tropical spastic paraparesis
76. HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy
77. The influence of HLA class I alleles and heterozygosity on the outcome of human T cell lymphotropic virus type I infection
78. Free major histocompatibility complex class I heavy chain is preferentially targeted for degradation by human T-cell leukemia/lymphotropic virus type 1 p12(I) protein
79. Long terminal repeat structure of an American isolate of type I human T-cell leukemia virus
80. HTLV-1 p27rex stabilizes human interleukin-2 receptor alpha chain mRNA
81. A rat model of human T lymphocyte virus type I (HTLV-I) infection: In situ detection of HTLV-I provirus DNA in microglia/macrophages in affected spinal cords of rats with HTLV-I-induced chronic progressive myeloneuropathy
82. Sequences downstream of the RNA initiation site regulate human T-cell lymphotropic virus type I basal gene expression
83. Involvement of transcription factor YB-1 in human T-cell lymphotropic virus type I basal gene expression
84. Increase of CCR1 and CCR5 expression and enhanced functional response to MIP-1 alpha during differentiation of human monocytes to macrophages
85. Eradication of human T-lymphotropic virus type 1 by allogeneic bone-marrow transplantation
86. Lymphoid organs as a major reservoir for human T-cell leukemia virus type 1 in experimentally infected squirrel monkeys (Saimiri sciureus): Provirus expression, persistence, and humoral and cellular immune responses
87. Specific regions of contact between human T-cell leukemia virus type I Tax protein and DNA identified by photocross-linking
88. Identification of a human T-cell leukemia virus type I tax peptide in contact with DNA
89. Increased HTLV-I proviral DNA in HTLV-I-associated myelopathy: A quantitative polymerase chain reaction study
90. Presence of HTLV-I proviral DNA in central nervous system of patients with HTLV-I-associated myelopathy
91. In vivo genomic variability of human T-cell leukemia virus type I depends more upon geography than upon pathologies
92. In vitro infection of human macrophages by human T-cell leukemia/ lymphotropic virus type I (HTLV-I)
93. The p12I, p13II, and p30II proteins encoded by human T-cell leukemia/lymphotropic virus type I open reading frames I and II are localized in three different cellular compartments
94. In vivo infection of human T-cell leukemia virus type I in non-T cells
95. + lymphocytes in the spinal cord from patients with HTLV-I-associated myelopathy
96. Nucleo-cytoplasmic redistribution of the HTLV-I Rex protein: Alterations by coexpression of the HTLV-I p21x protein
97. Cerebrospinal fluid interferon-gamma is increased in HTLV-I-associated myelopathy
98. Granulocytemacrophage colony-stimulating factor and interleukin-1 increase in cerebrospinal fluid, but not in serum, of HTLV-I-associated myelopathy
99. In situ demonstration of the HTLV-I genome in the spinal cord of a patient with HTLV-I-associated myelopathy
100. Control of cAMP-regulated enhancers by the viral transactivator Tax through CREB and the coactivator CBP
101. In vitro and in vivo functional analysis of human T cell lymphotropic virus type 1 pX open reading frames I and II
102. Host sequences flanking the human T-cell leukemia virus type 1 provirus in vivo
103. Basis of HTLV type 1 target site selection
104. Expression of c-fos, c-myb, and myc in human monocytes: Correlation with monocytic differentiation
105. Detection of human T-lymphotropic, virus type I (HTLV-I) tax RNA in the central nervous system of HTLV-I-associated myelopathy/tropical spastic paraparesis patients by in situ hybridization
106. In vitro transcription of human T-cell leukemia virus type 1 is RNA polymerase II dependent
107. Human T-cell leukemia virus type 1 Tax requires direct access to DNA for recruitment of CREB binding protein to the viral promoter
108. HTLV-1 transactivator induces interleukin-2 receptor expression through an NF-kappa B-like factor
109. Immunologic analysis of a spinal cord-biopsy specimen from a patient with human T-cell lymphotropic virus type I-associated neurologic disease
110. Extensive latent retroviral infection in bone marrow of patients with HTLV-I-associated neurologic disease
111. Neuronal molecular mimicry in immune-mediated neurologic disease
112. IL-15 and IL-2: A matter of life and death for T cells in vivo
113. Induction of nuclear NF-kappa B DNA binding activity after exposure of lymphoid cells to soluble tax1 protein
114. Extracellular Tax1 protein stimulates tumor necrosis factor-beta and immunoglobulin kappa light chain expression in lymphoid cells
115. Dendritic cell lineage, plasticity, and cross-regulation
116. Abnormal in vitro proliferation and differentiation of T cell colony-forming cells in patients with tropical spastic paraparesis/human T lymphocyte virus type I (HTLV-I)-associated myeloencephalopathy and healthy HTLV-I carriers
117. Dendritic cells from patients with tropical spastic paraparesis are infected with HTLV-1 and stimulate autologous lymphocyte proliferation
118. The role of human T-lymphotropic virus type 1 (HTLV-1)-infected dendritic cells in the development of HTLV-1-associated myelopathy/tropical spastic paraparesis
119. Production of functionally deficient dendritic cells from HTLV-Iinfected monocytes: Implications for the dendritic cell defect in adult T cell leukemia
120. Quantitative proviral DNA and antibody levels in the natural history of HTLV-I infection
121. In vivo analysis of human T-cell leukemia virus type 1 reverse transcription accuracy
122. A 36-kilodalton cellular transcription factor mediates an indirect interaction of human T-cell leukemia/lymphoma virus type I TAX1 with a responsive element in the viral long terminal repeat
123. Activation of interleukin-2 receptor alpha expression by extracellular HTLV-I Tax1 protein: A potential role in HTLV-I pathogenesis
124. Transcriptional cross-talk: Nuclear factors CREM and CREB bind to AP-1 sites and inhibit activation by Jun
125. + HTLV-1-specific cytotoxic T cells
126. Analysis of CREB mutants in Tax complex formation and trans-activation
127. Constitutively activated Jak-STAT pathway in T cells transformed with HTLV-I
128. Pathogenesis and prevention of HTLV-1-associated diseases
129. Molecular pathways in virusinduced cytokine production
130. + hematopoietic progenitors and leukemic cells and mediates transendothelial migration induced by stromal cell-derived factor-1
131. Differences in expression of transcription factor AP-1 in human promyelocytic HL-60 cells during differentiation towards macrophages versus granulocytes
132. + T lymphocytes
133. Twostep nature of human T-cell leukemia virus type 1 replication in experimentally infected squirrel monkeys (Saimiri sciureus)
134. Lymphocyte traffic control by chemokines
135. Transcription factor AP-2 activates gene expression of HTLV-I
136. The human T-cell leukemia/lymphotropic virus type 1 p12I proteins bind the interleukin-2 receptor beta and gammac chains and affects their expression on the cell surface
137. Hematopoietic progenitor cells from patients with adult T-cell leukemia-lymphoma are not infected with human T-cell leukemia virus type 1
138. Analysis of HTLV-I proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLV-I carriers: High proviral load strongly predisposes to HAM/TSP
139. + cells in patients with HTLV-I-associated myelopathy/tropical spastic paraparesis: Correlation with HTLV-I provirus load
140. + T cells are an in vivo reservoir for human T-cell lymphotropic virus type I
141. Detection of tumor necrosis factor-alpha-positive cells in cerebrospinal fluid of patients with HTLV-I-associated myelopathy
142. Sequence analysis of human T cell lymphotropic virus type I strains from southern India: Gene amplification and direct sequencing from whole blood blotted onto filter paper
143. Differential expression of Rel/NF-kappaB and octamer factors is a hallmark of the generation and maturation of dendritic cells
144. + T lymphocytes
145. HTLV-1 p12(I) protein enhances STAT5 activation and decreases the interleukin-2 requirement for proliferation of primary peripheral blood mononuclear cells
146. Interaction of cellular proteins with the human T-cell leukemia virus type I transcriptional control region. Purification of cellular proteins that bind the 21-base pair repeat elements
147. Binding of hostcell factors to DNA sequences in the long terminal repeat of human T-cell leukemia virus type I: Implications for viral gene expression
148. Interleukin-6 in cerebrospinal fluid of HTLV-I-associated myelopathy
149. Nationwide survey of HTLV-I-associated myelopathy in Japan: Association with blood transfusion
150. Limited sequence variation in human T-lymphotropic virus type 1 isolates from North American and African patients
151. Recognition of bZIP proteins by the human T-cell leukaemia virus transactivator tax
152. Transformation of human umbilical cord blood T cells by human T-cell leukemia/lymphoma virus
153. Modulating the immune response with dendritic cells and their growth factors
154. Sensing pathogens and tuning immune responses
155. Differentiation of monocytes into dendritic cells in a model of transendothelial trafficking
156. Nucleotide sequence analysis of isolates of human T-lymphotropic virus type 1 of diverse geographical origins
157. Studies of the immortalizing activity of HTLV type 1 Tax, using an infectious molecular clone and transgenic mice
158. Functional interaction of the HTLV-1 transactivator Tax with activating transcription factor-4 (ATF4)
159. Human T cell leukemia virus type I (HTLV-I) molecular genotypes and disease outcome
160. In vivo cellular tropism of human T-cell leukemia virus type 1
161. Immortalization of CD4(+) and CD8(+) T lymphocytes by human T-cell leukemia virus type 1 Tax mutants expressed in a functional molecular clone
162. Interactions between brain endothelial cells and human T-cell leukemia virus type 1-infected lymphocytes: Mechanisms of viral entry into the central nervous system
163. Induction of cytotoxic T lymphocyte and antibody responses to enhanced green fluorescent protein following transplantation of transduced CD34(+) hematopoietic cells
164. HIV-1 LTR C/EBP binding site sequence configurations preferentially encountered in brain lead to enhanced C/EBP factor binding and increased LTR-specific activity
165. Chronic inhibition of glutamate uptake produces a model of slow neurotoxicity
166. Tax-induced HTLV-I LTR transcriptional activation is modulated by phosphorylation
167. + T cells
168. Developmental plasticity of CNS microglia
169. Cross-talk in signal transduction: TPA-inducible factor jun/AP-1 activates cAMP-responsive enhancer elements
170. The oncoprotein tax binds the src-1-interacting domain of cbp/p300 to mediate transcriptional activation
171. Regulatory elements involved in tax-mediated transactivation of the HTLV-I LTR
172. Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro
173. Human T-cell lymphotropic virus type 1-infected T lymphocytes impair catabolism and uptake of glutamate by astrocytes via Tax-1 and tumor necrosis factor alpha
174. Long-term effects of HTLV-1 on brain astrocytes: Sustained expression of Tax-1 associated with synthesis of inflammatory mediators
175. A new regulatory element that augments the Tax-dependent enhancer of human T-cell leukemia virus type 1 and cloning of cDNAs encoding its binding proteins
176. Cytokine induction in HTLV-I associated myelopathy and adult T-cell leukemia: Alternate molecular mechanisms underlying retroviral pathogenesis
177. Identification of human T-cell lymphotropic virus type 1 21-base pair repeat-specific and glial cell-specific DNA-protein complexes
178. The tax protein of human T-cell leukemia virus type 1 mediates the transactivation of the c-sis/ platelet-derived growth factor-B promoter through interactions with the zinc finger transcription factors Sp1 and NGFI-A/Egr-1
179. Human T cell leukemia virus type I (HTLV-I) and human diseases
180. Immunocytochemical analysis of the cellular infiltrate in the spinal cord lesions in HTLV-I-associated myelopathy
181. Apoptosis of T lymphocytes in the spinal cord lesions in HTLV-I-associated myelopathy: A possible mechanism to control viral infection in the central nervous system
182. Cytokine expression in the spinal cord lesions in HTLV-I-associated myelopathy
183. Expression of adhesion molecules and monocyte chemoattractant protein-1 (MCP-1) in the spinal cord lesions in HTLV-I-associated myelopathy
184. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in HTLV-I-associated myelopathy
185. Transcription factors that regulate monocyte/macrophage differentiation
186. Binding of the human T-cell leukemia virus Tax protein to the coactivator CBP interferes with CBP-mediated transcriptional control
187. Expanding dendritic cells in vivo enhances the induction of oral tolerance
188. HTLV-I Tax protein stimulation of DNA binding of bZIP proteins by enhancing dimerization
189. Monocyte-driven activation-induced apoptotic cell death of human T-lymphotropic virus type I-infected T cells
190. Contrasting roles of IL-2 and IL-15 in the life and death of lymphocytes: Implications for immunotherapy
191. Specialized roles of the chemokine receptors CCR1 and CCR5 in the recruitment of monocytes and T(H)1-like/CD45RO(+) T cells
192. Immune reactivity in the nervous system: Modulation of T-lymphocyte activation by glial cells
193. AP-1 derived from mature monocytes and astrocytes preferentially interacts with the HTLV-I promoter central
194. Characterization of a glial cell-specific DNA-protein complex formed with the human T cell lymphotropic virus type I (HTLV-I) enhancer
195. Sp family members preferentially interact with the promoter proximal repeat within the HTLV-I enhancer
196. The dynamics of HTLV-I and the CTL response
197. Is there a balance between microglia and astrocytes in regulating Th1/Th2-cell responses and neuropathologies?
198. Transcriptional suppression of the human T-cell leukemia virus type I long terminal repeat occurs by an unconventional interaction of a CREB factor with the R region
199. Molecular interactions between the coactivator CBP and the human T-cell leukemia virus Tax protein
200. Human T cell lymphotropic virus type I genomic expression and impact on intracellular signaling pathways during neurodegenerative disease and leukemia
201. + cytotoxic T lymphocytes
202. Protein domains involved in both in vivo and in vitro interactions between human T-cell leukemia virus type I tax and CREB
203. Mechanism of transcriptional activation of viral and cellular genes by oncogenic protein of HTLV-1
204. Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease
205. Human T-lymphotropic virus type 1 p30(II) functions as a transcription factor and differentially modulates CREB-responsive promoters
206. Human T-cell lymphotropic virus type I (HTLV-I) transcriptional activator, tax, enhances CREB binding to HTLV-I 21-base-pair repeats by protein-protein interaction